Neurocrine Biosciences Inc (NBIX)

Days of inventory on hand (DOH)

		Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020
Inventory turnover		18.17	21.55	22.60	24.96	24.26	30.97	27.41	24.65	22.12	19.77	23.82	22.64	19.12	21.03	17.41	14.79	15.40	20.76	18.05	17.95
DOH	days	20.09	16.93	16.15	14.63	15.05	11.79	13.32	14.81	16.50	18.46	15.32	16.12	19.09	17.36	20.97	24.67	23.70	17.58	20.22	20.33

December 31, 2024 calculation

DOH = 365 ÷ Inventory turnover
= 365 ÷ 18.17
= 20.09

The days of inventory on hand (DOH) for Neurocrine Biosciences Inc has shown fluctuations over the analyzed period. Initially, the company maintained its inventory for around 20 days between March 2020 and June 2020. This number decreased slightly to 17.58 days by September 2020, indicating a potential improvement in managing inventory levels.

However, there was a notable increase in DOH to 23.70 days by December 2020, which further rose to 24.67 days by March 2021. This extended timeframe suggests a potential buildup of inventory or slower sales during that period.

From June 2021 onwards, there was a gradual decrease in DOH, reaching as low as 13.32 days by June 2023. This declining trend indicates more efficient management of inventory, leading to reduced holding periods and potentially lower carrying costs.

Although there was a slight uptick in DOH to 20.09 days by December 2024, the overall trend showcases an improvement in inventory turnover and management efficiency over the analyzed period. A lower DOH generally indicates better liquidity, as it implies faster conversion of inventory into sales, reducing the risk of obsolescence or excess holding costs.